and we lead the program with the latest development in the treatment of copa 19 in the u.s. food and drug administration on monday authorized emergency use of eli lilly s experiment mental anti-body treatment. that s balm let me be mocked the f.d.a. said the emergency use authorization was given based on clinical trials showing the drug reduced the need for hospitalization or emergency room visits and high risk tobit 1000 patients now the regulator added that it can be used now for treating patients over the age of 12 with mild to moderate symptoms but cannot be used for patients who have been hospitalized due to cope at 19 lilly is hoping to supply as many as 1000000 doses of the treatment in the 4th quarter of this year now the u.s. government previously made an agreement with the drug maker for the early supply of the medication on the news lately stock was up as much as 4 percent throughout the day. and following the news that pfizer bio and texaco but 1000 vaccine candid
joe biden, to be president elect someone that s not words, final vote, determination. and we aren t there yet once the election free and fair. and what is the possibility of the country election? and this is boom, bust of the one business show you can t afford to miss boring. washington coming up . the developments in the field of cope with $900.00 treatment continue to roll with the f.d.a. has approved a major anybody treatment that s straight ahead plus markets are still on the move following positive vaccine news coming up, we analyzed the wave of stock stories and where this rally could lead, and later amazon is facing the hot seat in europe as the block has moved to open a new investigation into the e-commerce behemoth with a packed show today. so let s dive right in and we lead the program with the latest development in the treatment of copa 19 in the u.s. food and drug administration on monday, authorized emergency use of eli lilly s experiment, mental anti-body treatm
but 19 vaccine candidate showed an efficacy of 90 percent. the european commission will sign a deal to secure up to 300000000 doses of the experimental drug. the president of the european commission said they will authorize the deal on wednesday after quote, working tirelessly to secure doses of a potential vaccine. in the last few months. german health minister, yes. on tuesday had confirmed the block was ready to secure at least 200000000 doses of pfizer s drug adding. they had also made deals with other drug makers. with bio in tech, as announced yesterday. you commission president this vanderlei and we will be able to bring the negotiations to a conclusion very quickly. in any case, the mention of at least 200000000 doses for the european union is secured. now it just has to be finally secured in the contract. and meanwhile, biotech s head of strategy, ryan richardson was asked about profiting from the development a drug that receives funding from the german government du
yes or no? and this is a boom bust of the one business show you can t afford to miss. boring watching things coming up. the developments in the field of covert $900.00 treatment continue to roll if the f.d.a. has approved a major anybody. treatment. that s straight ahead, plus markets are still on the move following positive vaccine news coming up, we analyzed the wave of stock stories and where this rally could lead. and later amazon is facing the hot seat in europe as the block has moved to open a new investigation into the e-commerce behemoth with a packed show today. so let s dive right in and we lead the program with the latest development in the treatment of copa 19 in the u.s. food and drug administration on monday, authorized emergency use of eli lilly s experiment, mental anti-body treatment. that s balm. let me be about the f.d.a. said the emergency use authorization was given based on clinical trials showing the drug reduced the need for hospitalization or emergenc
drug reduced the need for hospitalization or emergency room visits and high risk. tobit 1000 patients. now the regulator added that it can be used now for treating patients over the age of 12 with mild to moderate symptoms, but cannot be used for patients who have been hospitalized due to cope. at 19, lilly is hoping to supply as many as 1000000 doses of the treatment in the 4th quarter of this year. now the u.s. government previously made an agreement with the drug maker for the early supply of the medication on the news. lately stock was up as much as 4 percent throughout the day. and following the news that pfizer and biotech scope in 1000 vaccine candidate showed an efficacy of 90 percent, the european commission will sign a deal to secure up to $300000000.00 doses of the experimental drug. the president of the european commission said they will authorize the deal on wednesday after quote, working tirelessly to secure doses of a potential vaccine. in the last months germa